Douglass Winthrop Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Douglass Winthrop Advisors's OGN Position: Q4 2021 in Review
Douglass Winthrop Advisors sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 10,206 shares — an estimated $335K sold.
Douglass Winthrop Advisors first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $3.37M in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.
- Douglass Winthrop Advisors reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
- Douglass Winthrop Advisors sold 10,206 Organon & Co shares in Q4 2021, an estimated $335K.
- Douglass Winthrop Advisors first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
- Douglass Winthrop Advisors's Organon & Co position peaked at $3.37M in Q2 2021.
- 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.
Based on Douglass Winthrop Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.